We had previously demonstrated that ROCK2 was overexpressed and RhoE, an antagonist of the Rho/ROCK signaling, was underexpressed in HCC and together they promote HCC metastasis [13, 14]. Here, RND3 is linked to hepatocellular carcinoma.